SENZOLO, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.717
EU - Europa 748
AS - Asia 581
SA - Sud America 4
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 8.059
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.707
CN - Cina 425
IT - Italia 187
FI - Finlandia 160
DE - Germania 127
SE - Svezia 125
VN - Vietnam 104
GB - Regno Unito 79
IN - India 36
IE - Irlanda 16
UA - Ucraina 16
FR - Francia 12
CA - Canada 7
NL - Olanda 7
RO - Romania 6
JP - Giappone 4
TW - Taiwan 4
BR - Brasile 3
ES - Italia 3
GR - Grecia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BE - Belgio 2
ET - Etiopia 2
HK - Hong Kong 2
MX - Messico 2
NZ - Nuova Zelanda 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
CH - Svizzera 1
EC - Ecuador 1
EU - Europa 1
IQ - Iraq 1
IR - Iran 1
MA - Marocco 1
PL - Polonia 1
PR - Porto Rico 1
RS - Serbia 1
SI - Slovenia 1
Totale 8.059
Salva come PNG Salva come JPEG
Città #
Fairfield 1.208
Woodbridge 698
Chandler 598
Houston 560
Ashburn 524
Ann Arbor 495
Seattle 422
Cambridge 404
Wilmington 341
San Diego 158
Princeton 132
Beijing 122
Medford 120
Dong Ket 104
Des Moines 101
Helsinki 88
Roxbury 69
Nanjing 61
Padova 51
Boardman 46
Guangzhou 44
Jacksonville 42
Shenyang 26
London 24
Shanghai 19
New York 18
Dearborn 16
Pune 15
Washington 15
Hebei 14
Munich 13
Dublin 11
Hefei 11
Jinan 11
Milan 11
Ogden 11
Changsha 10
Kilburn 9
Redwood City 9
Tianjin 9
Chicago 8
Cologno Monzese 8
Nanchang 8
Phoenix 8
Esslingen am Neckar 7
Kunming 7
Vicenza 7
Zhengzhou 7
Chiswick 6
Fuzhou 6
Jiaxing 6
Borås 5
Kharkiv 5
Ningbo 5
Nürnberg 5
Paris 5
Rockville 5
Rome 5
Bologna 4
Dolo 4
Norwalk 4
Taipei 4
Trieste 4
Venezia 4
Lozzo Atestino 3
São Paulo 3
Tappahannock 3
Tivoli 3
Tokyo 3
Acton 2
Addis Ababa 2
Amsterdam 2
Biassono 2
Brussels 2
Central 2
Chengdu 2
Florence 2
Fremont 2
Gazzo 2
Groningen 2
Gurgaon 2
Hangzhou 2
Hounslow 2
Indiana 2
Lappeenranta 2
Las Vegas 2
Modena 2
Moosburg 2
Orange 2
Prescot 2
Rovigo 2
San Jose 2
Santa Ursula 2
Toronto 2
Venice 2
Weimar 2
Aachen 1
Adliswil 1
Ankara 1
Atlanta 1
Totale 6.850
Salva come PNG Salva come JPEG
Nome #
The animal naming test: An easy tool for the assessment of hepatic encephalopathy 188
Cavoportal hemitransposition associated to portoportal anastomosis for liver transplant in portomesenteric thrombosis. 157
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 157
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. 141
Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy 139
18F-fluorodeoxyglucose positron emission tomography study of brain metabolism in cirrhosis: effect of liver transplantation 121
Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis 116
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 113
Does decreased fibrinolysis have a role to play in the development of non-neoplastic portal vein thrombosis in patients with hepatic cirrhosis? 111
Markers of acute rejection and graft acceptance in liver transplantation. 105
A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis 101
Short-term outcomes of pediatric liver transplant recipients after transition to Adult Healthcare Service 100
Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study 100
Normal cortical regional cerebral blood flow justifies the normal neuropsychological performance in patients with cholestatic liver disease 99
Whole blood rotation thromboelastometry (ROTEM®) profiles in subjects with non-neoplastic portal vein thrombosis. 99
A Prioritization Model for Liver Transplantation Based on a Dual Waiting List: A Prospective Controlled Study 99
Factor VIIa-antithrombin complexes in patients with non-neoplastic portal vein thrombosis with and without cirrhosis. 99
Outcome of a First Episode of Bacterial Infection in Candidates for Liver Transplantation 99
Outcome of critically ill cirrhotic patients admitted to the ICU: The role of ACLF 97
Obliterative portal venopathy without portal hypertension: An underestimated condition 95
Interventional treatment should be incorporated in the algorithm for the management of patients with portal vein thrombosis 91
Increased anticoagulant response to low-molecular-weight heparin in plasma from patients with advanced cirrhosis 90
Orthotopic Liver Transplantation in Alcoholic Liver Disease Patients 90
Eradication of HCV in patients awaiting liver transplantation does not increase drop-out due to HCC progression 90
Non Adherence To Medical Prescriptions In Liver Transplantation: A Prospective Longitudinal Study 90
Perioperative thrombotic complications in liver transplantation 89
Neuropsychological alterations in hepatitis C infection: the role of inflammation. 88
Successful pregnancy in Alagille Syndrome. 85
A Longitudinal, Prospective Study On Adherence To Medical Regimen Before and After Liver Transplantation 85
Predictors of Response To Anticoagulant Therapy For the Treatment of Portal Vein Thrombosis (pvt) In Cirrhosis Patients 84
Cyanoacrylate injection to treat recurrent bleeding from Dieulafoy's lesion. 81
Hemodynamic Evaluation of Nonselective β-Blockers in Patients with Cirrhosis and Refractory Ascites 81
USE OF ANTI-HBc POSITIVE DONORS IN LIVER TRANSPLANTATION: THE EXPERIENCE OF PADUA LIVER TRANSPLANT CENTRE 81
Drop-out rate due to HCC progression is not affected by HCV eradication with DAAs in patients awaiting liver transplantation 80
Thromboelastometry hypercoagulable profiles and portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma 79
Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features 79
Hepatitis C virus and liver transplantation: Where do we stand? 77
Levels of angiogenic proteins in plasma and platelets are not different between patients with hepatitis B/C-related cirrhosis and patients with cirrhosis and hepatocellular carcinoma 77
HCV eradication is not associated with drop-out due to HCC progression in patients awaiting liver transplantation: A monocentric experience 77
Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis 77
Who Fares Worse After Liver Transplantation? Impact of Donor and Recipient Variables on Outcome: Data from a Prospective Study. 77
New insights into the coagulopathy of liver disease and liver transplantation 76
Recurrent facial dyskinesias due to extrapontine myelinolysis 76
Effect of Low Molecular Weight Heparin (lmwh) On Thrombin Generation In Cirrhotic Patients At Different Stages of Liver Disease 76
Therapeutic approaches for portal biliopathy: A systematic review 76
Neuropsychiatric performance and treatment of hepatitis C with direct-acting antivirals: a prospective study 76
Prioritization Tools To Predict Short and Long Term Mortality Following Liver Transplantation 75
Liver transplantation for viral hepatitis in 2015 74
Tips for portal vein thrombosis (pvt) in cirrhosis: Not only unblocking a pipe 73
Beneficial role of terlipressin in decompensated cirrhotics with spontaneous bacterial peritonitis 72
Acute Allograft Rejection After Liver Transplantation: Incidence, Risk Factors and Impact On Outcome 70
Management of Severe Bleeding in Liver Disease and Transplantation 70
No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma 70
Geotrichum capitatum Invasive Infection Early After Liver Transplant 70
Endothelial damage of the portal vein is associated with Heparin-like effect in advanced stages of cirrhosis 69
Acute kidney injury is associated with increased levels of circulating microvesicles in patients with decompensated cirrhosis 68
Does Once-Daily Tacrolimus (Advagraf) Increase Adherence to Immunosuppressive Therapy in Liver Transplanted Patients? 67
Management of the critically ill patient with cirrhosis: A multidisciplinary perspective 66
Local prothrombotic state in portal venous system in cirrhosis 66
Anticoagulation for portal vein thrombosis in cirrhotic patients should be always considered 66
Antibiotic therapy for spontaneous bacterial peritonitis in acute-on-chronic liver failure: Handle with care 65
Estimation of Liver Transplant Related Survival Benefit: The Devil Is in the Details 65
Lack of agreement for defining 'clinical suspicion of rejection' in liver transplantation: a model to select candidates for liver biopsy. 64
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis in patients with decompensated liver cirrhosis: results of a randomized controlled clinical trial 64
Evaluation of Physician Agreement For Defining "clinical Suspicion of Rejection" In Liver Transplantation 64
Screening and treatment of portal vein thrombosis in cirrhosis 63
Rethinking the role of non-selective beta blockers in patients with cirrhosis and portal hypertension 61
PERIPHERAL NK CELLS IN PATIENTS WITH HCV RECURRENCE AFTER LIVER TRANSPLANTATION DURING INTERFERON-FREE ANTIVIRAL THERAPY 61
Long-term medical and psycho-social evaluation of patients undergoing orthotopic liver transplantation for alcoholic liver disease 61
Acute Cellular Rejection in Liver Transplanted Patients: Incidence, Risk Factors, and Impact on Outcome 60
Fibrosis Progression in Non Responders to Antiviral Treatment (AT) in HCV Recurrence Following Liver Transplantation (LT): An Italian Multicenter Retrospective Study 59
Transjugular intrahepatic portosystemic shunt in non-cirrhotic portal hypertension related to cystic fibrosis in a lung transplant patient 59
Letter: clinical outcomes of patients with hepatitis D infection in the liver transplant setting 58
Biodegradable Biliary Stents for Percutaneous Treatment of Post-liver Transplantation Refractory Benign Biliary Anastomotic Strictures 55
Diagnostic and prognostic role of presepsin in patients with cirrhosis and bacterial infection 55
Effects of Early Placement of Transjugular Portosystemic Shunts in Patients With High-Risk Acute Variceal Bleeding: a Meta-analysis of Individual Patient Data 54
Determinants of increased thrombotic tendency in NASH cirrhosis: not there yet! 54
Self-Reported Adherence to Medical Prescriptions before and after Liver Transplantation: A Longitudinal Study 53
A Commentary on the Interplay Between Severity of Liver Disease and Bacterial Infection in Hospitalized Patients with Cirrhosis 53
The concept of Quality of Life in organ transplantation 52
Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort study 51
Management of Portal Vein (pvt) and Splacnic Veins Thrombosis (svt) In Liver Transplantation Candidates 49
Managment of Nonneoplastic Portal Vein Thrombosis in the Setting of Liver Trasplantation: a Systematic Review 47
Effect of low molecular weight heparin (LMWH) on thrombin generation in cirrhotic patients 46
Hypnotic Hallucination of Body Heating Modifies Splanchnic Circulation: Haemodynamic and Ultrasonographic Pilot Study in Normal Volunteers 46
Coagulopathy is not predictive of bleeding in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure 46
Current and future perspective on targeted agents and immunotherapies in hepatocellular carcinoma 46
Management of portal hypertension severe complications 45
Hepatocellular carcinoma risk in patients with HBV-related liver disease receiving antiviral therapy 45
Drug induced liver injury: from pathogenesis to liver transplantation 45
Veno occlusive disease: up-date on clinical menagement. 44
Increased thrombin generation in liver transplant recipients: does immunosuppressive therapy play a role? 44
Algorithm for the management of portal vein thrombosis: a prospective study in patients with liver cirrhosis 42
Liver Fibrosis and Steatosis in Alstrom Syndrome: A Genetic Model for Metabolic Syndrome 41
Algorithm For the Management of Portal Vein Thrombosis (pvt) In Patients With Cirrhosis: A Prospective Case-control Study 39
A prospective longitudinal assessment of de novo metabolic syndrome after liver transplantation 39
Role of local endothelial alterations in the pathogenesis of portal vein thrombosis in cirrhosis 37
Machine learning in liver transplantation: a tool for some unsolved questions? 37
More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC 37
Effect of Low Molecular Weight Heparin (lmwh) On Thrombin Generation (tg) In Cirrhotic Patients 36
Totale 7.482
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.870
article - articoli 31.654
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 194
Totale 64.718
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019551 0 0 0 0 0 0 0 0 0 115 236 200
2019/20201.632 176 73 40 195 166 122 168 186 183 148 133 42
2020/20211.277 71 76 110 79 63 53 58 106 162 158 137 204
2021/20221.740 61 177 218 106 72 185 99 157 67 86 154 358
2022/20231.269 238 120 37 130 226 146 19 97 152 11 84 9
2023/2024719 41 146 100 76 79 103 72 30 28 44 0 0
Totale 8.213